Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Chemsex / Party-and-Play (PnP)

Methamphetamine, GHB/GBL, Mephedrone, Sexual-Health & Overdose Risks and Harm Reduction

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not applicable (illicit/recreational drug use context)

Reference only. Not medical advice.

What can go wrong

The acute headline risk is GHB/GBL overdose: a steep dose-response curve, delayed onset prompting dangerous re-dosing, and lethal synergy with alcohol and other depressants can cause sudden unconsciousness, aspiration, respiratory depression, and death, with no routine reversal agent. Methamphetamine carries risks of dependence, stimulant psychosis, cardiovascular events, and severe depressive come-downs. Injecting ('slamming') adds HIV and hepatitis C transmission risk where equipment is shared. Across the pattern, disinhibition and prolonged sessions are associated with condomless sex, multiple partners, and higher STI/HIV acquisition, and intoxication compromises consent and capacity. These harms are highly responsive to non-judgmental harm reduction and linkage to care.

This is something to take to a clinician. The Atlas can tell you what is known about chemsex / party-and-play (pnp) in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Chemsex (also 'party and play' or PnP) is the intentional use of specific drugs to initiate, enhance, and prolong sex, a pattern documented predominantly among MSM in urban centers. The core drugs are methamphetamine ('crystal', 'Tina'), GHB/GBL (gamma-hydroxybutyrate / gamma-butyrolactone, 'G'), and mephedrone (a cathinone). The sexual-health risks are interlinked: disinhibition and prolonged sessions are associated with condomless sex, multiple partners, and higher STI/HIV transmission, while injecting ('slamming') adds bloodborne-virus risk. The most acute danger is GHB/GBL overdose: its dose-response curve is extremely steep, the effective and toxic doses are close, and combining it with alcohol or other depressants can cause sudden loss of consciousness, respiratory depression, and death. Harm reduction (dosing, timing, never mixing G with depressants, never dosing for someone else, recovery position, and connection to care) reduces harm. Cross-links: sti-hiv, sti-prep, psy-depression-suicide.

The specific combination of drugs used to facilitate and prolong sex carries distinct overdose and sexual-health risks, and a distinct harm-reduction playbook.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Understanding the chemsex drug repertoire and its risks
  • Counseling on GHB/GBL overdose prevention
  • Harm-reduction for injecting ('slamming') and bloodborne viruses
  • Linking chemsex to PrEP, STI screening, and mental-health support

How it works

Methamphetamine is a potent dopaminergic/noradrenergic releaser producing euphoria, hypersexuality, prolonged wakefulness, and reduced judgment; it is highly dependence-forming and can cause cardiovascular strain, psychosis, and severe come-downs. GHB/GBL acts on GABA-B and GHB receptors as a CNS depressant producing disinhibition and libido at low doses; GBL is a pro-drug rapidly converted to GHB and is more potent. Mephedrone is a synthetic cathinone with combined stimulant and empathogenic effects. The danger of GHB/GBL is pharmacokinetic: a narrow therapeutic window, steep dose-response, short duration prompting re-dosing, and dangerous synergy with other CNS depressants.

Why GHB/GBL overdose ('going under') is the headline danger

The gap between a recreational dose of G and an overdose can be as little as a fraction of a milliliter, and effects are delayed enough that users re-dose before the first dose peaks ('stacking'). The result is sudden deep unconsciousness, vomiting with aspiration risk, bradycardia, and respiratory depression. There is no reversal agent in routine use; management is supportive (airway, recovery position, emergency services). Combining G with alcohol, benzodiazepines, ketamine, or opioids sharply increases the risk of fatal respiratory depression. Practical harm reduction: precise measured dosing (a marked syringe), strict timing intervals with a written log, never mixing with depressants, never dosing an unconscious or asleep person, and placing anyone who goes under in the recovery position and calling for help.

Safety in detail

  • GHB/GBL: never combine with alcohol or other depressants; measure precisely; log timing
  • If someone 'goes under': recovery position, do not leave alone, call emergency services
  • Methamphetamine: dependence, psychosis, cardiac strain, severe come-down/depression
  • Slamming (injecting): use sterile equipment, never share, link to needle programs and BBV testing
  • Consent and capacity are compromised under heavy intoxication

What people get wrong

  • Often saidGHB is safe because it's natural / used in tiny amounts

    ActuallyG has one of the steepest dose-response curves of any recreational drug; small overshoots or mixing with alcohol can cause sudden unconsciousness and death. 'Natural' says nothing about safety.

  • Often saidChemsex is just partying and not a health issue

    ActuallyBeyond acute overdose, chemsex is associated with higher STI/HIV transmission, injecting-related bloodborne viruses, dependence, and significant mental-health harm, but it is highly responsive to non-judgmental harm-reduction and support.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

What we do not know

  • What treatment models best address methamphetamine dependence in the chemsex context (no approved pharmacotherapy)?
  • How to expand low-threshold, non-judgmental chemsex support beyond a few major cities?

At a glance

Core drugs
Methamphetamine, GHB/GBL ('G'), mephedrone
Most acute danger
GHB/GBL overdose (steep dose-response)
Injecting term
'Slamming', adds bloodborne-virus risk
Sexual-health link
Condomless sex, multiple partners, STI/HIV
Key G rule
Never combine G with alcohol/depressants

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Chemsex / Party-and-Play (PnP). A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Bourne et al. (Chemsex study, Sigma Research/LSHTM)2014

    Foundational qualitative study characterizing chemsex among MSM in South London, the drugs involved, and harm patterns

  • Maxwell, Shahmanesh & Gafos, Int J Drug Policy2019

    Systematic review of chemsex-associated harms including STI/HIV, mental health, and overdose

  • Hockenhull et al. (GHB/GBL deaths), forensic toxicology series2017

    Documented GHB/GBL-related deaths, frequently involving co-ingested depressants and the steep dose-toxicity relationship